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Synopsis 
The binding of carboplatin to His-15 in hen egg white lysozyme in non-NaCl conditions is reported 
and thus removes the effect of carboplatin partially converting to cisplatin in the high NaCl conditions 
used previously. This study also investigates several criteria to determine the diffraction resolution 
limit. 
Abstract 
Hen egg white lysozyme (HEWL) co-crystallisation conditions of carboplatin without sodium 
chloride (NaCl) have been utilised to eliminate partial conversion of carboplatin to cisplatin observed 
previously. Tetragonal HEWL crystals were successfully obtained in 65% MPD with 0.1M citric acid 
buffer at pH 4.0 including DMSO. The X-ray diffraction data resolution to be used for the model 
refinement was reviewed using several topical criteria together. The CC1/2 criterion implemented in 
XDS led to data being significant to 2.0Å, compared to the data only being able to be processed to 
3.0Å using the Bruker software package (SAINT). Then using paired protein model refinements and 
DPI values based on the FreeR value, the resolution limit was fine tuned to be 2.3Å. Interestingly this 
was compared with results from the EVAL software package which gave a resolution limit of 2.2Å 
solely using <I/sigI> crossing 2, but 2.8Å based on the Rmerge values (60%). The structural results 
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showed that carboplatin bound to only the Nδ binding site of His-15 one week after crystal growth, 
whereas five weeks after crystal growth, two molecules of carboplatin are bound to the His-15 
residue. In summary several new results have emerged: - firstly non-NaCl conditions showed a 
carboplatin molecule bound to His-15 of HEWL; secondly binding of one molecule of carboplatin 
was seen after one week of crystal growth and two molecules were bound after five weeks of crystal 
growth; and thirdly the use of several criteria to determine the diffraction resolution limit led to the 
successful use of data to higher resolution. 
 
1. Introduction 
Cisplatin and carboplatin are platinum anti-cancer drugs which have been used for a long time in the 
fight against cancer by targeting DNA. However, 90% of their reported binding is to plasma proteins 
(Fischer et al 2008). Thus, these drugs cause toxic side effects. Cisplatin is rapidly converted to toxic 
metabolites which cause nephrotoxic effects (Zhang, 1996; Huliciak et al, 2012), whereas carboplatin 
is less toxic due to the addition of the cyclobutanedicarboxylate moiety, which has a slower rate of 
conversion. Carboplatin can therefore be tolerated by patients at higher doses compared to cisplatin 
(Kostova, 2006). Previous crystallographic studies of cisplatin and carboplatin with hen egg white 
lysozyme (HEWL), a model protein, have shown binding of two molecules to its His-15 residue in 
dimethyl sulfoxide (DMSO) media (Tanley et al, 2012a; 2012b; Helliwell & Tanley 2013) and for 
cisplatin even after prolonged exposure in an aqueous medium (Tanley et al, 2012b). Subsequently, 
through public archiving of our  raw diffraction images at Utrecht University (Tanley et al, 2013, 
http://rawdata.chem.uu.nl/#0001;) and now also mirrored at the Tardis Raw data archive in Australia 
(http://vera183.its.monash.edu.au/experiment/view/40/), a collaboration was set up with one of the 
authors of this article (KD) who downloaded and re-processed the diffraction images, measured in 
Manchester, with the XDS software package  (Kabsch, 2010) to compare with our previous results. 
Reviewing these results along with the previous publication of the carboplatin bound structures in 
DMSO media studied at cryo and room temperatures (Tanley et al, 2012a; Tanley et al, 2012b) (PDB 
id’s 4dd7, 4dd9 and 4g4c) it was noted that the anomalous difference electron density peaks within 
the carboplatin binding sites weren’t only for the Pt centres (Tanley et al, 2014, Accepted for 
publication in the Journal of Synchrotron Radiation). Thus, this suggested that with the high sodium 
chloride (NaCl) concentrations used in our crystallisation conditions (Tanley et al, 2012a; 2012b; 
Helliwell & Tanley, 2013) the carboplatin could be partially converted to cisplatin, with the extra 
anomalous difference density thereby being attributed to the Cl atoms of cisplatin. This partial 
conversion of carboplatin has been seen previously in solution (Gust & Schnurr, 1999). Due to these 
new findings, the binding sites could thus contain a mixture of carboplatin and cisplatin rather than 
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just the carboplatin molecule, which is what we initially thought was solely bound (Tanley et al, 2014, 
Accepted for publication in the Journal of Synchrotron Radiation).  
Based on these new findings, this study focuses on crystallising HEWL with carboplatin in non-NaCl 
conditions to remove the possibility of carboplatin converting to cisplatin. Crystals were successfully 
grown without NaCl and the results are presented here. The raw diffraction data images for these 
MPD chemical medium grown crystals were processed using the Bruker software program (SAINT) 
as well as EVAL (Schreurs et al, 2010) and XDS (Kabsch, 2010).  
Determining the high resolution cut off limit for X-ray crystallographic data is a major discussion 
point  (Diederichs & Karplus, 2013; Evans & Murshudov, 2013), with Rmerge values being used for 
many years (Arndt et al, 1968) and in recent years supplanted by monitoring where <I/sigI> crosses a 
value of 2.0. Rmerge measures the relative spread of n independent measurements of the intensity of a 
reflection around their average. A relatively new criterion has been implemented, CC1/2, which is 
based on the Pearson correlation coefficient of two half datasets (Karplus & Diederichs, 2012; Evans, 
2011). Our  study looks to determine the high resolution cut off of our newly processed datasets using 
these multiple criteria and, notably, to see if one can use data to a higher resolution than indicated 
from <I/sigI> crossing 2.0. 
Several new results have emerged: - Firstly non-NaCl conditions show a carboplatin molecule bound 
to His-15 of HEWL; secondly binding of one molecule of carboplatin was seen after one week of 
crystal growth and two molecules were bound after five weeks of crystal growth; and thirdly the use 
of several criteria combined allowed us to more carefully assess the diffraction resolution limit than 
hitherto. 
2. Methods 
2.1. Crystallisation conditions. 
20mg of HEWL (0.6mM) was dissolved in 1ml distilled water. 1.4mg of carboplatin (1.8mM) was 
added in a 3-fold molar excess over that of the protein, along with 75µl DMSO and mixed until all the 
carboplatin had dissolved. 48 non-NaCl crystal screens from Hampton were set up; these comprised 
2µl protein/carboplatin/DMSO solution aliquots each mixed with 2µl reservoir solution and were set 
up in hanging drop crystallisations with 1ml of reservoir solution. Crystallisation trays were left at 
room temperature and crystals grew after ~ 4 weeks in the condition: 65% MPD with 0.1M citric acid 
buffer at pH 4.0. The citrate ions removing a proton from the histidine nitrogen(s) would start 
immediately after mixing the solutions. 
2.2. X-ray diffraction data collection, protein structure solution and model refinement 
IUCr     
 
 
  4 
 
A 0.3mm sized crystal grown in the 65% MPD conditions was mounted into a loop with silicon oil 
used as the cryoprotectant and X-ray diffraction data were measured one week after crystal growth 
(crystals took ~ 4 weeks to grow). The crystal was mounted on a Bruker APEXII home source 
diffractometer and data collection was carried out at 110K with a data collection strategy used to gain 
the most information possible. A second crystal (0.1mm sized), five weeks after initial crystal growth, 
was mounted into a loop again with silicon oil used as the cryoprotectant. The crystal was again 
mounted on the same Bruker APEXII home source diffractometer and X-ray diffraction data 
collection was carried out at 127K with a data collection strategy again used to gain the most 
information possible. The two crystal datasets were processed using the Bruker software package 
(SAINT) as well as EVAL (Schreurs et al, 2010) and XDS (Kabsch, 2010) software packages. The 
structures were solved using molecular replacement with PHASER (McCoy et al, 2007) and 
restrained refinement with CCP4i REFMAC5 (Vagin et al, 2004), using the reported lysozyme 
structure 2w1y as molecular search model (Cianci et al 2008). Model building, adjustment and 
refinement were carried out respectively using the COOT (Emsley & Cowtan, 2004) molecular 
graphics programme and REFMAC5 (Vagin, 2004) in CCP4i. Ligand binding occupancies were 
calculated using SHELXTL (Sheldrick, 2008). Crystallographic and refinement parameters for 
crystals 1 and 2 processed using the SAINT, EVAL and XDS software packages are summarized in 
Table 1. 
Table 1  
X-ray crystallographic data and final protein model refinement statistics for crystals 1 and 2, processed by 3 
different software packages. 
 Crystal 1 Crystal 2 
 Bruker 
(SAINT) 
EVAL XDS Bruker 
(SAINT) 
EVAL XDS 
PDB id Not 
deposited 
4lt0 4lt1 Not 
deposited 
4lt2 4lt3 
Data collection 
temperature (K) 
110 110 110 127 127 127 
Data reduction 
Space group P43212 P43212 P43212 P43212 P43212 P43212 
Unit cell parameters 
(Å)/(°) 
a=b= 76.97   
c= 36.28 
α=β=γ= 90.0 
a=b= 76.77  
c= 36.36 
α=β=γ= 90.0 
a=b= 76.82   
c= 36.47 
α=β=γ= 90.0 
a=b= 77.12   
c= 36.54 
α=β=γ= 90.0 
a=b= 77.29   
c= 36.63 
α=β=γ= 90.0 
a=b= 77.12   
c= 36.56 
α=β=γ= 90.0 
Protein molecular Mass 14700 14700 14700 14700 14700 14700 
Molecules per asymmetric 
unit 
1 1 1 1 1 1 
IUCr     
 
 
  5 
 
$a <I/sigI> = 2.4 at 2.2Å, <I/sigI> = 1.7 at 2.15Å 
$b <I/sigI> = 2.0 at 2.24Å 
$c <I/sigI> = 2.3 at 2.07Å, <I/sigI> = 1.7 at 2.03Å 
$d <I/sigI> = 2.17 at 2.17Å, <I/sigI> = 1.77 at 2.11Å 
* Final refinement statistics to 2.1Å for crystal 1 processed by EVAL, whereas the data reduction statistics are 
to 2.0Å; see also Table 2 a and b. 
** Final refinement statistics to 2.3Å for crystal 1 processed by XDS, whereas the data reduction statistics are to 
2.0Å; see also Table 2 a and b. 
 
3. Results 
3.1 Data processing 
Data processing of the raw diffraction images was carried out using SAINT (Bruker internal 
software), the XDS package (Kabsch, 1988) and EVAL (Schreurs et al, 2010). The use of these three 
Detector to crystal 
distance (mm) 
40.20 40.20 40.20 40.37 40.37 40.37 
Observed reflections 58539 202135 231303 187183 169869 206299 
Unique reflections 4211 7770 7765 6323 7901 7850 
Resolution (Å) (last shell) 36.28 – 3.00          
(3.10 – 3.00) 
19.18– 2.00 
(2.03 – 2.00) 
39.41 – 2.00 
(2.05 – 2.00) 
36.54 – 2.16 
(2.19-2.16) 
25.15 – 2.00 
(2.04 – 2.00) 
39.41 – 2.00 
(2.05 – 2.00) 
Completeness (%) 99.8 (99.1) 99.8 (99.8) 99.7 (99.8) 100 (100) 98.9 (93.7) 99.4 (32.4) 
Rmerge (%)  0.255 (0.563) 0.340 (2.71) 0.422 (3.935) 0.227 (0.738) 0.193 (1.41) 0.248 (2.27) 
(I/σ(I)) 11.4 (2.8) 9.2 (0.9)$a 8.9 (0.5)$b 14.4 (2.01) 14.2 (1.1)$c 14.6 (0.5)$d 
Multiplicity 23.9 (9.8) 26.1 (12.3) 29.7 (9.8) 29.6 (13.3) 21.6 (5.2) 26.3 (6.0) 
CC1/2 - 0.38 0.16 - 0.51 0.32 
Cruickshank DPI (Å) 0.59 0.25* 0.27** 0.24 0.21 0.19 
Average B factor (Å
2
) 22.3 26.8* 24.4** 25.5 22.8 27.6 
Refinement 
R factor/ R free  20.2/28.9 22.3/28.3* 18.5/24.8** 18.4/26.0 20.7/26.5 19.5/25.7 
R factor all 20.6 22.6* 18.8** 18.8 21.0 19.8 
RMSD bonds (Å)/ Angles 
(°) 
0.011/ 1.634 0.016/1.888* 0.014/1.644*
* 
0.015/1.691 0.016/1.815 0.014/1.650 
Ramachandran values (%) 
Most favoured  92.1 96.1 96.8 96.8 96.1 97.6 
Additional allowed 7.9 3.9 3.2 3.2 3.9 2.4 
Disallowed  0 0 0 0 0 0 
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different processing programs for crystal 1 in this case was vital, with the SAINT (Bruker) software 
processing the data to 3.0Å resolution (<I/sigI> = 2.8 to 3.0Å), while processing to higher resolutions 
failed. However using XDS, we found that based on the CC1/2 criterion (Karplus & Diederichs, 2012) 
there was information in the data up to 2.0Å resolution. Using EVAL, the data would have been cut at 
2.2Å based on where <I/sigI> cross 2, or 2.8Å based on the Rmerge values of this dataset exceeding 
60%. However, as the CC1/2 values from the XDS processing showed data out to 2.0Å resolution still 
carried information, the raw diffraction data images were also processed to 2.0Å resolution using 
EVAL. Due to the differences in the resolution limit chosen between SAINT, EVAL and XDS, 
separate pairwise refinements were used for the XDS and EVAL data to determine which resolution 
was optimal (Table 2), along with the DPI values based on the FreeR value (Figure 1), with 2.3Å 
being chosen via either criterion for the XDS processed raw diffraction data images and 2.1Å for the 
EVAL processed raw diffraction data images. The best final model obtained from the XDS and 
EVAL data, respectively, was used for calculation of R-values against both datasets, allowing 
unambiguous identification of the best data and model (Table 3), with the EVAL processed data and 
model to 2.1Å resolution being marginally better than the XDS processed data and model to 2.3Å. 
Table 2 Pairwise refinements (Karplus & Diederichs, 2012) showing R/Rfree of initial models 
refined at given resolution (top row), against data as given in left column. (a) XDS data and (b) is the 
EVAL data. Bold numbers indicate improvement of Rfree compared to refinement at lower 
resolution. The resolution which yields the consistently best model is highlighted in yellow; this 
resolution cut-off is hereby determined as optimal for these data, the given protein model, the 
refinement strategy and refinement program. 
 
 
  
  
  
  
Resolutio
n used for 
R-value 
calculatio
n 
  Resolution that model was refined at 
  3.0A 2.5 Å 2.4 Å 2.3 Å 2.2 Å 2.1 Å 2.0 Å 
3.0 Å 16.4/28.7 16.1/28.4 16.2/28.8 16.3/28.5 16.3/28.4 16.3/28.4  16.3/28.1 
2.5 Å   17.7/25.6  17.6/26.2 17.7/25.4 17.6/25.4 17.6/25.5 17.6/25.4 
2.4 Å     17.9/25.7  17.9/25.7 17.9/25.6 17.9/25.6 17.9/25.5  
2.3 Å       18.5/24.8  18.6/24.7 18.5/24.7 18.8/24.8 
2.2 Å         18.8/25.9 18.8/25.9 18.8/25.9  
2.1 Å           19.7/27.2  19.7/27.3  
2.0 Å             21.3/28.4 
  Resolution that model was refined at 
(a) 
(b) 
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Figure 1  DPI value based on the FreeR factor for each refined model at different resolutions for 
both the XDS and EVAL processed raw diffraction data images. The FreeR set was kept the same for 
both the XDS and EVAL processed datasets. The curves are the line of best fit through the data points 
using a power 5/2 fit (Our data follows the same trends as in Blow, 2002) in OriginPro 8.5.1 with the 
line showing excellent agreement with the data points .  
Table 3 The pairwise comparison technique applied to the XDS and EVAL data and final refined 
models. The best model obtained from the XDS and EVAL data, respectively, was used for 
calculation of R-values against both datasets, allowing unambiguous identification of the best data 
and model. Highlighting in yellow shows the EVAL final model and data at 2.1Å resolution has lower 
Rfree compared to the XDS model against the EVAL data. Also, the EVAL final model has the same 
Rfree as the XDS final model against the XDS data.  
 
 
 
Resolutio
n used for 
R-value 
calculatio
n 
 3.0A 2.5 Å 2.3 Å 2.15 Å 2.1 Å 2.05 Å 2.0 Å 
3.0 Å 19.2/28.7 19.0/27.4 18.9/28.0 18.9/27.7 18.6/27.4 18.9/27.9 18.9/27.6 
2.5 Å  20.7/29.9  20.7/30.1 20.7/29.8 20.5/29.4 20.7/29.6 20.2/29.6 
2.3 Å   21.1/28.3  21.3/28.4 21.3/28.3 21.3/28.3 21.3/28.2 
2.15Å    22.1/28.3  22.1/28.2 22.2/28.3 22.2/28.3 
2.1 Å     22.3/28.3 22.4/28.3 22.3/28.3 
2.05Å      22.5/28.9 22.5/28.9 
2.0 Å       23.1/29.2 
IUCr     
 
 
  8 
 
 Resolution that model was refined at 
  2.1 Å EVAL 2.3 Å XDS 
Resolution used for R-
value calculation 
2.1 Å EVAL 22.3/28.3 24.4/29.5 
2.3 Å XDS 20.9/24.8 18.5/24.8 
 
3.2 Carboplatin binding to His-15 
For crystal 1, collected one week after crystal growth shows carboplatin bound to the Nδ binding site 
of His-15 at 3.0Å from the SAINT (Bruker) internal software package (Figure 2a), 2.3Å from the 
XDS (Figure 2b) software package and 2.1Å from the EVAL (Figure 2c) software package. The 
models at 2.3Å and 2.1Å (Figures 2b and c) show slightly more detail in the 2Fo-Fc map at the Nδ 
binding site, as more detail for the atoms bound to the Pt centre can be seen compared to just the Pt 
atom being visible in the density to 3.0Å. Binding of the carboplatin molecule to the Nε atom 
however, is not seen. The anomalous difference density is however weak as determined from all three 
software packages, with the highest peak being 5.1σ at the Pt position, when the data was cut to 4.0Å 
resolution (Table 4). 
 
 
 
 
 
 
 
 
 
Figure 2 Binding of carboplatin to the Nδ atom of His-15 from crystal 1 at (a) 3.0Å from the SAINT 
(Bruker) processed data (b) 2.3Å from the XDS processed data and (c) 2.1Å from the EVAL 
processed data. 2Fo-Fc maps are shown at the 1.2σ cut off level. Anomalous difference electron 
density (orange) maps are shown at the 3.0σ cut off level. No anomalous difference electron density 
was present in the Bruker dataset map (a). 
 
For crystal 2 (Figure 3), collected five weeks after crystal growth shows binding of two molecules of 
carboplatin, one each bound to the Nδ and the Nε atom of His-15. The same as for crystal 1, the 
(a) (b) 
(C) 
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anomalous difference density for the Pt atoms is weak, with the highest peak being 4.6σ for the Nδ 
binding site and 5σ for the Nε binding site (Table 4). 
 
 
 
 
 
 
 
 
 
Figure 3 Binding of carboplatin to the Nδ and Nε atoms of His-15 for crystal 2 at (a) 2.16Å from the 
SAINT (Bruker) processed data (b) 2.0Å from the XDS processed data and (c) 2.0Å from the EVAL 
processed data. 2Fo-Fc maps are shown at the 1.2σ cut off level. Anomalous difference electron 
density (orange) maps are shown at the 3σ cut off level. 
 
Table 4 Anomalous difference density peak heights for the Pt position at both the Nδ and Nε 
binding sites for crystals 1 and 2 along with the occupancy values of the Pt atoms, calculated using 
SHELX (Sheldrick, 2008). 
 Nδ Nε 
 Anomalous 
peak height 
(σ) 
Pt 
occupancy 
(%) 
Anomalous 
peak height 
(σ) 
Pt 
occupancy 
(%) 
Crystal_1_Bruker 0 47 - - 
Crystal_1_EVAL 5.1 39 - - 
Crystal_1_XDS 3.4 29 - - 
Crystal_2_Bruker 4.1 42 4.6 16 
Crsytal_2_EVAL 4.6 22 5.0 31 
Crystal_2_XDS 4.4 23 3.1 38 
 
4.0 Discussion 
4.1 Carboplatin binding to His-15 in non-NaCl conditions 
Crystals were grown in 65% MPD with 0.1M citric acid buffer at pH 4.0 after ~4 weeks, and one 
week after crystal growth one molecule of carboplatin was seen bound to the Nδ atom of His-15 
(a) 
(c) 
(b) 
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(Figure 2). However, no binding was seen to the Nε binding site. At the low pH used (pH 4.0) in these 
crystallisation conditions, the His-15 residue is assumed to be a protonated histidine, which means 
that both N-hydrogen atoms would need to be removed before binding to the Pt centre can be 
achieved at these histidine nitrogens. In the earlier studies we have observed binding of two molecules 
of cisplatin and carboplatin to His-15 in HEWL (Tanley et al, 2012a; 2012b; Helliwell & Tanley, 
2013), one to each nitrogen, and was determined to be due to the histidine residue being an imidazolyl 
anion which is formed by the removal of the usual N-hydrogen atoms, which could be brought about 
by either the Cl or acetate ions in the co-crystallisation conditions used in those studies (Tanley et al, 
2012a). However, as the MPD crystallisation conditions do not contain either Cl or acetate ions, this 
leaves the citrate ions in the crystallisation mixture deemed to be able to extract an N-hydrogen atom. 
As these crystals took 4 weeks to grow and then were measured both one week and five weeks after 
crystal growth, the chemistry of the citrate ions removing a proton from the histidine nitrogen(s) 
would start immediately after the conditions were set up. Thus, the equilibrium in de-protonation of 
the His N atoms and binding to cisplatin is reached slower compared to the previous crystallisation 
conditions which include the Cl and acetate ions as only one binding site for carboplatin is seen one 
week after the crystals have grown (take ~4weeks to grow), compared to the two binding sites we 
previously saw after around 8 days of crystallisation (Tanley et al, 2012a;  2012b; Helliwell & 
Tanley, 2013). For the case of our second crystal, which was measured five weeks after crystal 
growth, binding of two molecules of carboplatin to the His-15 residue is seen (Figure 3). Thus, the 
extraction of the second N-hydrogen atom took longer due to the relatively low concentration of 
citrate ions in these MPD medium crystallisation conditions. The occupancy values for the Pt atoms in 
this study (mean occupancy of ~30% for both the Nδ and Nε binding sites, Table 4) are lower 
compared to the occupancies seen when the crystals were grown in the high NaCl conditions used 
previously (~70% for the Nδ binding site and ~50% for the Nε binding site) (Tanley et al, 2012a; 
2012b; Helliwell & Tanley, 2013).  
  
4.2 Determining the diffraction resolution of the data 
 
As well as now seeing just carboplatin bound in the MPD conditions, this study also looked at the use 
of combining several criteria to determine the diffraction resolution limit of these data, and indeed 
which led to the successful use of data to higher resolution. The CC1/2 criterion in particular (Karplus 
& Diederichs, 2012; Diederichs & Karplus, 2013) for determining the resolution limit for a given 
dataset meant that for crystal 1, data to a higher resolution was used compared to using the traditional 
statistics to determine the resolution limit of the data (Rmerge values or where <I/sigI> crosses 2). 
Once the data were processed and refined, the pairwise refinements technique (Karplus & Diederichs, 
2012; Diederichs & Karplus, 2013) was used to determine which resolution was best for these data. In 
IUCr     
 
 
  11 
 
this case, using CC1/2 (Table 1), the pairwise refinement technique (Table 2) and the DPI value 
(Cruickshank, 1999)  of the refined model using the Rfree factor (Figure 1), led to 2.3Å resolution 
being determined for the XDS processed diffraction data images and 2.1Å resolution for the EVAL 
processed diffraction data images for crystal one, compared to 3.0Å from SAINT (the Bruker internal 
software package), with attempts to process the data to higher resolution using SAINT failing to 
produce any results. In Table 2, the highlighting in bold represents the improvement in R/Rfree values 
against the resolution used to refine the model and for the XDS case the refined model at 2.3Å 
resolution has the lowest R/Rfree gap (6.3) of all the models, meaning that for the XDS processed 
data, 2.3Å resolution is most probably the optimum high resolution cut off to use for this dataset, but 
is not clear cut. However, for the EVAL processed data, it is clear that 2.1Å resolution is the optimum 
resolution to use for this dataset. The graphs of the DPI values based on the Rfree value (Figure  2) 
agrees with these results from the pair-wise refinement technique as at these resolutions, one can see a 
flattening off of the curve agreeing with the results in Blow, 2002. Plotting the natural logs of the DPI 
values and the resolution (Supplementary Figure 1), EVAL shows a power law of 2.4 and XDS 2.3, ie 
very close to the theory value of 2.5 (Blow, 2002) which shows that the DPI is proportional to the 
power 5/2. Interestingly, the XDS processed dataset to 2.3Å resolution has a very similar DPI value to 
the EVAL processed dataset to 2.1Å resolution. If the CC1/2 criterion had not been available, this 
dataset would have been processed by EVAL to 2.8Å based on the Rmerge values being higher than 
60% and using <I/sigI> crossing 2 this was 2.2Å but had an Rmerge value of 140%. Thus, processing 
these data with multiple software packages with these different criteria to determine the overall 
resolution limit led to use of higher resolution.  
The best model obtained from the XDS and EVAL data, respectively, was used for calculation of R-
values against both datasets, allowing unambiguous identification of the best data and model (Table 
3). From these pair-wise refinements, it is determined that the EVAL processed data to 2.1Å and the 
final refined model is marginally better than the XDS processed data to 2.3Å and its final refined 
model. The reason why the R-values (Rwork/Rfree) of the best model against the XDS data are about 
2% lower than the best model against the EVAL data is not known to us, and this question is currently 
under investigation. 
The higher high-resolution limit of the EVAL data compared with the XDS data is consistent with the 
CC1/2 values reported by EVAL  at 2.1Å resolution (80%) and XDS at 2.3Å resolution (75%) 
respectively.  
As a further comparison for crystal 2, this dataset was processed to 2.16Å by SAINT, which was 
where the <I/sigI> value crossed 2, but with CC1/2 implemented in both XDS and EVAL, this dataset 
was processable to 2.0Å; the edge of the detector, which therefore limited the high resolution for 
crystal 2.  
IUCr     
 
 
  12 
 
Comparing the XDS and EVAL unscaled and scaled data for crystal 1 leads to a number of 
conclusions about this particular dataset; (i) the statistics of the EVAL data including the CC1/2 
criterion are slightly better than XDS. (ii) The difference between XDS and EVAL is that large 
intensity reflections are larger in EVAL than XDS. (Supplementary Figure 2a) (iii) The standard 
deviations of individual reflections in EVAL are larger than in XDS (Supplementary Figure 2b). The 
difference is largely caused by SADABS and XSCALE applying different error models. SADABS 
relies heavily on internal standard deviations (iv) The refinement results are better (~2% lower 
Rfactors) for XDS. (v) The correlation between the F’s from XDS and EVAL is very good, except for 
the lowest resolution, where some reflections are partially screened by the beam stop, the definition of 
the beam stop being slightly different in EVAL from XDS. 
 
5.0 Conclusions 
The study outlined here shows carboplatin bound to the Nδ and Nε atoms of His-15 from HEWL in 
non-NaCl conditions, thus removing the possibility of carboplatin partially converting to cisplatin in 
high salt conditions seen previously (Tanley et al 2014, Accepted for publication in the Journal of 
Synchrotron Radiation).  
This study also looked at the use of several criteria to determine the resolution range of the datasets. 
Using CC1/2, the pairwise refinement technique and the DPI value based on FreeR, 2.1Å was 
confirmed as the best resolution limit to use for the EVAL processed raw diffraction images.  
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Supplementary Materials 
Figure S1 Natural log graph of the DPI value based on Rfree against the resolution limit of the 
refined model for both the XDS and EVAL processed datasets. One would expect a power law of 2.5 
based on equation 9 of Blow, 2002. The EVAL data has a power law of 2.4, and XDS 2.3, but both 
datasets follow the same trend (Figure 1), similar to the results in Blow, 2002. 
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Figure S2 Comparison between XDS and EVAL for the data of crystal 1. (a) Log10 (intensity) of 
reflections, which are larger in EVAL (horizontal) than XDS (vertical) and (b) I/σ comparison of 
EVAL vs XDS data. The error model in SADABS, used for the EVAL data, is largely responsible for 
the observed differences in I/σ. 
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